Spire Wealth Management - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,000
-33.3%
3,540
+39.4%
0.00%
Q3 2021$3,000
-25.0%
2,5400.0%0.00%
Q1 2021$4,0002,5400.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders